Related Experiment Video
Updated: Feb 3, 2026

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
Published on: December 9, 2010
Optimizing concentrations of concomitant antiretrovirals by reducing etravirine doses: two case reports of complex
Jean-Simon Denault1,2, Jean-François Cabot1,3, Hugo Langlois1,4
1Faculty of Pharmacy, Université de Montréal, Montréal, QC, Canada.
Abstract:
We report the cases of two treatment-experienced HIV-infected patients with complex antiretroviral regimens that showed significant drug-drug interactions with etravirine. Unexpectedly high etravirine concentrations likely caused subtherapeutic levels of darunavir, elvitegravir and dolutegravir through concentration-dependent metabolic induction. Therapeutic drug monitoring allowed safe etravirine dose decreases to manage these interactions.
More Related Videos
11:56Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Related Concept Videos
Drug Concentrations: Measurements
Plasma...
Pharmacokinetics: Drug–Drug Interactions
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Drug Dosing: Infants and Children
Drug Dosing: Geriatric Patients
Drug Dosing: Obese Patients